People · Operator
Named in public records as an officer, director or promoter · active 2011–2021 · Biotechnology, Other Technology, Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| StrideBio, Inc. | — | Biotechnology | Series C | $57.7M | $1.5B | 2021 |
| Regroup Therapy Inc. | — | Other Technology | Series A | $19.5M | $129.6M | 2016 |
| Immuta, Inc. | — | Other Technology | Seed | $4.9M | $125.6M | 2015 |
| Armgo Pharma Inc | — | Pharmaceuticals | Pre-Seed | $1.0M | $47.3M | 2011 |
Sapan Shah at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Sapan Shah on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| John Harris | 1 | 20 |
| Robert Saunders | 1 | 18 |
| Richard Smith | 1 | 11 |
| Michael Martin | 1 | 11 |
| Clay Thorp | 1 | 10 |
| Robert Hughes | 1 | 6 |
| Andy Jenks | 1 | 5 |
| Shaan Gandhi | 1 | 4 |
| Andrew Marks | 1 | 4 |
| Karen Hong | 1 | 4 |
| Jordan Dolin | 1 | 3 |
| Matthew Carroll | 1 | 3 |
| Andrew A. Schiff | 1 | 3 |
| Christian Lawless | 1 | 3 |
| Erica Whittaker | 1 | 3 |
| Thomas Hall | 1 | 2 |
| Michael Schiller | 1 | 2 |
| Patrick Ritschel | 1 | 2 |
| Stewart Parker | 1 | 2 |
| Mike Dial | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.